Interstitial Cystitis Completed Phase 3 Trials for Adalimumab (DB00051)

Also known as: Cystitis, Interstitial / Interstitial Cystitides / Cystitis interstitial / Cystitis ulcerative

IndicationStatusPhase
DBCOND0028936 (Interstitial Cystitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01295814Efficacy Study of Adalimumab to Treat Interstitial CystitisTreatment